Pharmacists in Springville, New York


13 Pharmacists found in Springville
female pharmacist

Dr. Cheryl Marie Haag, PHARMD


Pharmacist
317 S Cascade Dr, Springville, NY 14141
716-592-1465    

male pharmacist

Dr. Dane Edward Munzek, PHARMD


Pharmacist
317 S Cascade Dr, Springville, NY 14141
716-592-1465    

male pharmacist

Mr. Darren W Love, RPH.


Pharmacist
184 So Cascade Dr, Springville, NY 14141
716-592-7031     716-592-7375



male pharmacist

Mr. David John Williams, RPH


Pharmacist
27 Franklin St, Springville, NY 14141
716-592-9065     716-592-9064

female pharmacist

Mrs. Elizabeth Ann Murphy, RPH


Pharmacist
40 W Main St, Springville, NY 14141
716-592-2836    

female pharmacist

Emily Margaret Tallman, PHARMD


Pharmacist
40 W Main St, Springville, NY 14141
716-592-2836    

female pharmacist

Jennifer Lynne Bevilacqua, RPH


Pharmacist
317 S Cascade Dr, Springville, NY 14141
716-592-1465     716-592-1474

female pharmacist

Sarah Ripstein


Pharmacist
13 E Main St, Springville, NY 14141
716-592-2026     716-592-2028

female pharmacist

Mrs. Shirley Fruth Barone, RPH


Pharmacist
40 W Main St, Springville, NY 14141
716-592-2836    

female pharmacist

Siobhan Ann Hacker


Pharmacist
40 W Main St, Springville, NY 14141
716-592-2836    

male pharmacist

Mr. Stephan D Seybolt


Pharmacist
184 S Cascade Dr, Springville, NY 14141
716-592-7031    

female pharmacist

Susan K Bancroft, RPH


Pharmacist
316 S.cascade Dr., Springville, NY 14141
716-592-1465    

male pharmacist

Dr. Valentine Hill, PHARMD


Pharmacist
40 W Main St, Springville, NY 14141
716-592-2836    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.